INTRODUCTION
Deletions of the 22q11.2 locus are among the most common chromosomal abnormalities and occur predominantly de novo . Children with the 22q11.2 deletion show a spectrum of cognitive deficits Bearden et al., 2001 ) and a high incidence of emotional problems in childhood, and $30% of them develop schizophrenia in adolescence or early adulthood (Pulver et al., 1994) . New 22q11.2 deletions account for 1%-2% of sporadic schizophrenia cases . Most affected individuals carry a 3 Mb deletion, whereas 7% have a nested 1.5 Mb deletion spanning 27 known genes.
Previous work has provided insights into the genetic basis of the psychiatric and cognitive symptoms observed in carriers of 22q11.2 deletions and implicated a subset of these genes including ZDHHC8 (Mukai et al., 2004) . Notably, a genetic variant of ZDHHC8 that modulates the complex splicing pattern at this locus was associated with schizophrenia in some cohorts of karyotypically normal patients (Mukai et al., 2004; Chen et al., 2004) . ZDHHC8 is a palmitoyltransferase belonging to a 23-member family of enzymes that share a conserved cysteinerich signature catalytic domain (DHHC domain) (Fukata and Fukata, 2010) . Protein palmitoylation describes the addition of the saturated 16-carbon palmitate lipid at specific cysteine residues by a liable thioester bond (el-Husseini and Bredt, 2002) and has emerged as a key reversible posttranslational protein modification involved in the protein trafficking and the regulation of diverse membrane and cytosolic proteins, especially in neurons (el-Husseini and Bredt, 2002) . The biochemical machinery involved has only recently been identified, and our earlier work established a connection between palmitoylation and neural signaling in vivo (Mukai et al., 2008) .
Using chromosomal engineering, we generated the Df(16)A +/À mouse model, which carries a 1.3 Mb chromosomal deficiency (Df(16)A) that is syntenic to the human 22q11.2 1.5 Mb deletion . We also reported the generation and characterization of a mouse strain carrying a deletion of the Zdhhc8 gene (Mukai et al., 2004; Mukai et al., 2008) . We have previously shown that Df(16)A +/À mice have reduced dendritic branching and spine density in hippocampal neurons, a phenotype, which is also observed in Zdhhc8-deficient mice (Mukai et al., 2008) . We also provided evidence that PSD95, a key postsynaptic protein, is one of the substrates of ZDHHC8, a finding replicated recently by Ho et al. (2011) and Yoshii et al. (2011) . As part of our systematic efforts to identify additional ZDHHC8 substrates, we made the unexpected discovery that Zdhhc8 deficiency affects palmitoylation of a number of proteins thought to regulate axonal growth and branching. By following up this finding, we present the results of a comprehensive analysis of axonal projections of pyramidal neurons from both Df(16)A +/À and Zdhhc8-deficient mice. We found that mutant mice have deficits in axonal growth during embryogenesis as well as in terminal arborization, which can be prevented by reintroduction of enzymatically active ZDHHC8. Impaired terminal arborization of pyramidal neurons is accompanied by a reduction in the strength of synaptic connections as well as altered functional connectivity and spatial working memory (WM) performance. Finally, using genetic and pharmacological rescue, we show that the effect of ZDHHC8 on axon growth is mediated in part via Cdc42-dependent modulation of Akt/Gsk3b signaling at the tip of the axon. The palmitoylationdependent changes in structural connectivity we describe represent possible predisposing factors to the psychiatric and cognitive symptoms associated with the 22q11.2 deletion.
RESULTS

Palmitoyl-Proteome in Zdhhc8-Deficient Neurons
To find substrates of ZDHHC8 palmitoyltransferase activity, we employed the acyl-biotinyl exchange (ABE) proteomic technol- (A) Palmitoylation levels of selected palmitoyl protein candidate substrates. Proteins, ABE-purified from cultured cortical neurons from WT and Zdhhc8 À/À mice, both in the presence (+) and absence (À) of hydroxylamine (HA), were analyzed by western blotting using the indicated specific antibodies. Palmitoylated proteins are expected to show HA-dependent detection. As a control, a portion of the starting protein sample (prior to ABE purification) was also screened. Palm, paralemmin; SYNT I, synaptotagmin I. Figure S1 .
ogy (Wan et al., 2007) , which purifies palmitoylated proteins from complex protein extracts. Proteins extracted from cultured mouse embryonic cortical neurons from Zdhhc8 À/À and wild-type (WT) mice at DIV21 were used for this analysis. We have previously shown that PSD95 is a ZDHHC8 substrate (Mukai et al., 2008; Ho et al., 2011) . Other proposed ZDHHC8 substrates include GAP43 (Mukai et al., 2008) and GRIP1 (Thomas et al., 2012) . ABE analysis showed that, compared with WT neurons, palmitoylation level of PSD95 was reduced by 30% in Zdhhc8 À/À (Zdhhc8
, 22 mice, n = 22; Zdhhc8 +/+ , 21 mice, n = 21, p < 0.0003) ( Figure 1A , 99%, 17 mice, n = 17; Zdhhc8 +/+ , 16 mice, n = 16, p > 0.1), which were not palmitoylated by ZDHHC8 in vitro (Mukai et al., 2008) , showed no change of palmitoylation level in Zdhhc8 À/À neurons as assayed by ABE. Having validated our approach, we looked for additional substrates. The strongest reduction of palmitoylation in Zdhhc8 À/À neurons was observed for Rho GTPases, Cdc42 and Rac1, which regulate actin cytoskeleton and cellular morphology inducing filopodia and lamellipodia in many cell types (Iden and Collard, 2008) , while in neurons they have been implicated in the regulation of axonal development and cell polarity (Tahirovic et al., 2010; Garvalov et al., 2007; Nishimura et al., 2005 Figure S1A available online).
Dissociated cortical neurons were cultured for 3 days, and axon polarity was analyzed by staining with anti-Tau-1 antibody as an axon-specific marker, anti-MAP2 antibody as a dendritic marker, and phalloidin to visualize the whole neuron. Control WT cortical neurons developed normal polarity, with most of them having a single axon and multiple dendrites (77.0% ± 0.9%), 3.4% ± 0.5% of neurons with multiple axons, and 19.6% ± 1.2% of neurons with no discernable axon. Zdhhc8 deficiency significantly reduced the portion of neurons having a single axon (Zdhhc8 +/À , 67.3% ± 1.3%, p < 0.0001;
Zdhhc8
À/À , 62.1% ± 1.8%, p < 0.0001) (Figures S1A and S1B). The axons of Zdhhc8-deficient neurons were also significantly shorter than those of the WT cells ( Figure S1C ). The length and number of dendrites were modestly, but significantly, reduced in Zdhhc8-deficient neurons ( Figures S1D and S1E ).
To elaborate further on this observation, dissociated cortical neurons were transfected with a plasmid for EGFP at DIV2 and cultured for 4 days before analysis of axon length and branching. Primary axon length was reduced in Zdhhc8 +/À and Zdhhc8 À/À neurons at DIV4 (341.2 ± 14.6 mm, n = 24, p < 0.05; 305.2 ± 22.2 mm, n = 24, p < 0.005), compared to Zdhhc8 +/+ neurons (421.4 ± 17.1 mm, n = 24) ( Figures 1C  and 1D ). Specifically, Zdhhc8 deficiency caused a decrease in the number of branch points in both Zdhhc8 +/À (4.0 ± 0.3, n = 24, p < 0.05) and Zdhhc8 À/À (3.3 ± 0.3, n = 24, p < 0.001) neurons compared to Zdhhc8 +/+ neurons (5.3 ± 0.3, n = 24; Figures 1C and 1D ), respectively. To confirm that the effect on axonal growth was directly mediated via ZDHHC8 transferase activity, we expressed the full-length enzymatically active form (ZDHHC8-FL) or an enzymatically inactive form (ZDHHC8-C134A) in cortical neurons from Zdhhc8 À/À mice.
In Zdhhc8 À/À neurons expressing ZDHHC8-FL (n = 24), the numbers of total branchpoints (5.2 ± 0.3, n = 24, p < 0.05) and primary axon length (397.0 ± 22.7, n = 24, p < 0.05) were restored to Zdhhc8 +/+ levels, whereas the enzymatically inactive form (n = 18) did not influence these parameters (Figures 1C and 1D) .
Prompted by these findings, we investigated further whether palmitoylation in general regulates axon polarity. The consequence of suppressing palmitoylation in developing neurons was examined using 2-bromopalmitate (2-BP), an inhibitor to palmitoyltransferase activity, to treat cultured cortical neurons during the transition from stage 2 to stage 3, a critical period in which rapid axonal growth and polarization occur (Yoshimura et al., 2006) . While most WT cells displayed a single neurite marked by the axonal marker Tau-1 (78.0% ± 0.5% of the cells), treatment with 2-BP reduced neurons with a single Tau-1-positive neurite (to 56.0% ± 1.1% of cells treated with 0.1 mM 2-BP) ( Figures S1F and S1G ). Both axons (Figures S1F and S1H) and MAP2-stained dendrites (Figures S1I and S1J) of treated cells were significantly shorter (in a dosagedependent manner) than that of untreated cells. In addition, analysis of axon branching at DIV4 (following treatment with 0.1 mM 2-BP) revealed a reduction in primary axon length compared to control neurons (288.0 ± 11.2 mm versus 432.5 ± 23.9 mm, n = 18, p < 0.001) as well as a significant decrease in the number of branchpoints compared to control neurons (2.3 ± 0.2 mm versus 5.8 ± 0.5 mm, n = 18, p < 0.005) (Figures S1M-S1P). Interestingly, 0.1 mM 2-BP treatment further reduced the portion of Zdhhc8 À/À single-axon cells compared to untreated Zdhhc8 À/À cells (49.8% ± 2.2% versus 62.0% ± 1.8%, Figures S1K and S1L), suggesting that other DHHC isoforms might also contribute to modulate neuronal polarity.
ZDHHC8 Activity Is Required for Axon Growth In Vivo
To determine the effect of ZDHHC8 activity on axon development in vivo, we used in utero electroporation to express EGFP in newly divided cortical neurons of Zdhhc8 À/À embryos and examine axon morphology at a single-cell resolution (Figure S2A) . Following electroporation at E14.5, embryos were placed back into the mother and allowed to develop for an additional 3 days (E17.5), at which point the morphology of EGFP-positive migrating neurons was examined. Electroporated neurons in both control and mutant cortices had migrated through the intermediate zone (IZ) and reached the cortical plate (CP) ( Figure S2A ), indicating that ZDHHC8 is dispensable for proper radial migration. When neuronal migration through the CP is completed, transfected layers 2/3 neurons show a polarized morphology with developing dendritic arbors and thin, straight axons. In WT brains, EGFP-expressing neurons show a typical basal axon and multiple apical dendrites derived from a single dendritic base ( Figures S2B and S2C Figures S2B and S2C ).
To investigate further the role of ZDHHC8 on axonal branching, plasmids encoding EGFP were electroporated in utero into the dorsolateral ventricular zone of the mouse forebrain at E15.5, and embryos were allowed to be born and develop to P8.5 for analysis. All cells labeled with EGFP completed their migration into layers 2/3 by P8.5. As shown previously (Jeanneteau et al., 2010) , callosal axons crossed the midline, coursed beneath the gray matter of the contralateral somatosensory cortex, penetrated the gray matter, and ascended to layers 1-3 and 5 ( Figure 2A) .
The number of callosal axon-terminal branches within the contralateral cortical layers 1-4 was decreased by disruption of Zdhhc8, with notably fewer secondary branches (total branch number, 34% Figure 2G ). To confirm that the effect on axonal branching was directly mediated via ZDHHC8 activity, we electroporated a construct driving both EGFP and ZDHHC8FL (ZDHHC8FL::IRES-EGFP) into Zdhhc8 À/À embryos in utero. Restricting our analysis to ipsilateral projections, we showed that ZDHHC8FL expression reversed the number of axonal branches in cortical layers 2-4 to WT levels ( Figures 2H and 2I ).
To examine whether reduced axonal arborization persists in adulthood, mice were electroporated with EGFP at E15.5 and were sacrificed at P56 to evaluate adult patterns of axonal branching. As shown previously in P21 brain (Courchet et al., 2013) , callosal axons of layers 2/3 pyramidal neurons branch extensively between P8.5 and P56 in contralateral layers 1-3 and layer 5 (Figures S2D and 2J) and ipsilateral layers 2/3 and layer 5 ( Figure 2K ) while avoiding branching in layers 4 and 6 both contralateral and ipsilateral hemispheres. We analyzed EGFP intensity in ipsilateral and contralateral axon target regions to quantify the complexity of axon branching. Zdhhc8 deficiency showed significantly reduced branching contralaterally in both layer 1 and 2/3 (Figure 2J) as well as ipsilaterally in layer 5 ( Figure 2L ).
Zdhhc8 Deficiency Disrupts Hippocampal Projections to mPFC and WM Performance
We have previously shown that 22q11.2 deletion lead to abnormal PFC-HPC coupling, similar to the one reported in schizophrenia patients (Sigurdsson et al., 2010) . Such longrange connectivity deficits may underlie deficits in cognition and other aspects of the clinical diagnosis. We have also reported an impairment of spatial WM in Df (16) +/À mice, which appears to be due in part to altered functional connectivity between the HPC and mPFC (Sigurdsson et al., 2010) . The circuit basis for this deficit may be complex, involving at least in part anatomical connections affected in terms of axonal extension and branching. We therefore asked whether Zdhhc8 deficiency disrupts the long-range projection from the HPC to mPFC and affects HPC-mPFC synchrony and WM performance. Initial analysis of axonal morphogenesis in primary hippocampal neurons collected from Zdhhc8-deficient mice and their WT littermates revealed a deficit of polarity as well as a pattern and degree of axonal arbor simplification ( Figures S3A-S3I ) very similar to those observed in Zdhhc8-deficient cortical neurons. Most importantly, deficits observed in vitro in neuronal cultures are recapitulated in the developing brains of mutant mice. Following in utero electroporation of an EGFP construct to ventral hippocampus (vHPC) at E16.5 ( Figure S3J ), the morphology of EGFP-positive axons was examined in sagittal brain sections during postnatal development. Labeled ventral field CA1axons in both Zdhhc8 +/+ and Zdhhc8 +/À projected normally to frontal regions of the cerebral cortex, extended rostrally through the lateral septal nucleus in the precommissural fornix, and reached the dorsal tenia tecta. At P16.5 a subset of fibers at the tenia tecta extended dorsally near the genu of the corpus callosum to the infralimbic area, prelimbic area, and anterior cingulated area ( Figure S3J ). At P16.5 the number of axon-terminal branches in the layer 5 of prelimbic mPFC was significantly reduced in Zdhhc8 +/À mice, with notably fewer secondary branches . To examine whether reduced axonal arborization persists in adulthood, we injected an adeno-associated virus (rAAV1/hSynapsin/EGFP) into CA1 in the vHPC at P56 (8 weeks), and mice were sacrificed at P84 (12 weeks) ( Figure S3L ). Evaluation of patterns of axonal branching in mPFC of Zdhhc8-deficient mice showed significantly reduced axon branching in layer 5 of prelimbic mPFC ( Figures  3D-3F ).
To examine the impact of Zdhhc8 deficiency on long-range functional connectivity and WM, Zdhhc8 +/À mice and their WT littermates were implanted with recording electrodes aimed at the ventral (vHPC) and dorsal hippocampus (dHPC), as well as the medial prefrontal cortex (mPFC). Neural activity was then recorded at baseline, and during training and testing in the T-maze delayed nonmatch to sample test of spatial WM. Behaviorally, Zdhhc8 +/À mice took significantly longer than WT mice to reach criterion performance on the T-maze task ( Figure 3G ). Zdhhc8
mice also showed lower theta-frequency (4-12 Hz) coherence between vHPC and mPFC as well as vHPC and dHPC after acquisition of the task ( Figures 3H-3K ). Although there was no statistically significant difference in theta coherence during a baseline session before training ( Figure 3L ), baseline theta coherence between vHPC and mPFC was inversely correlated with days to criterion ( Figure 3M ). Thus, the observed deficits in anatomical connectivity between vHPC and mPFC, due to Zdhhc8 deficiency, are accompanied by a disruption of functional connectivity between these two areas during behavior, which was narrower than that seen with the complete mutation (Df16(A) +/À mice; Sigurdsson et al., 2010) . In turn, disruption of the long-range projections from HPC to mPFC may contribute, possibly along with more localized deficits in pyramidal and inhibitory neuron function, to the impaired WM performance.
Disrupted Axonal Growth and Branching in Df (16) Figures S4A and S4B ), but to a lesser extent than in Figures 1A and 1B) . Figure 5A ) and ipsilaterally in layer 5 ( Figures 5B and 5C ). To assess whether a decrease in axonal branching of layer 2 pyramidal neurons was associated with a deficit in synaptic efficacy in L2-L5 neurons, we employed an optogenetic approach, in which a vector driving ChR2-Venus together with mCherry was delivered to L2 neurons by in utero electroporation at E16.5 ( Figure 5D ). Using acute coronal brain slices prepared from the frontal cortex of 8-week-old mice, we then performed extracellular recordings ipsilateral to the electroporated hemisphere ( Figure 5E ). Optical stimulation of the fibers and terminals of the transfected L2 neurons (expressing ChR2) triggered neurotransmitter release recorded as field EPSPs (fEPSPs) in L5 (Figures 5E and 5F). At higher stimulation intensities, the optically evoked fEPSPs were smaller in the Df(16)A +/À mice (n = 5, n = 11) compared to their WT littermates (n = 7, n = 16) ( Figure 5G , stimulation intensities 3-10, p < 0.05). To rule out the possibility that the observed difference in the input-output curve between genotypes could be due to different ChR2 expression in the activated axons, the input-output curves were normalized, and their similitude suggests that ChR2 levels were comparable in each group of activated axons ( Figure S5A , p > 0.05). It is known that the size of evoked fEPSPs depends on the number of synapses and on the probability of neurotransmitter release. In addition, the probability of vesicular release has been shown to be inversely proportional to the ratio of fEPSPs obtained using paired-pulse stimulation. Therefore, we performed paired-pulse stimulation to determine whether the differences in synaptic strength at higher stimulation intensities were due to differences in the probability of neurotransmitter release at the layer 2-5 synapses between genotypes. Lightevoked PPR was normal in Df (16) (legend continued on next page) amplitudes reflect differences in the number of functional synapses probably due to the decrease in axonal branching of layer 2 pyramidal neurons of Df(16)A +/À mice.
Signaling Pathways as Downstream Effectors of ZDHHC8 in Mediating Axonal Growth
Several of the ZDHHC8 substrates represent downstream effectors that could mediate the biological activity of ZDHHC8 on axon growth and branching. We focused on the reduction of palmitoylated Cdc42 in Zdhhc8-deficient neurons (Figure 1 ), given the well-established role of Cdc42 in axonal development and the fact that alterations in Cdc42 expression have been consistently reported in the brains of patients with psychiatric disorders, including schizophrenia (Gilks et al., 2012; Ide and Lewis, 2010) . Genetic ablation of Cdc42 leads to deficits in neuronal polarity and elongation of axons in cultured hippocampal neurons as well as in cortical neurons in vivo (Garvalov et al., 2007; Nishimura et al., 2005) , suggesting that Cdc42 may contribute to the axonal phenotypes emerging as a result of the Zdhhc8 deficiency. Alternative splicing gives rise to two different Cdc42 isoforms: a ubiquitously expressed canonical form (isoform 1) and a brain-specific form (isoform 2, Cdc42Palm) (Nishimura and Linder, 2013) . Canonical Cdc42 carries a CaaX motif (prenylation) at its C-terminal (CVLL), whereas Cdc42Palm carries a double-cysteine CCaX (CCIF) motif. Cdc42Palm is palmitoylated, whereas the canonical form is not (Nishimura and Linder, 2013; Kang et al., 2008) . Wirth et al. (2013) reported that the expression level of Cdc42Palm in the hippocampus was approximately 2-fold higher than that of isoform 1. We specifically examined the involvement of Cdc42Palm in axonal growth. Exogenous Cdc42Palm fused to EGFP (EGFP-CDC42Palm) is enriched at the axon tip at DIV3 ( Figure S6A ), whereas a mutant form with disrupted palmitoylation sites (EGFP-C2S) is diffusely localized in the entire cell ( Figure S6A) . A specific antibody against Cdc42Palm showed an enrichment of the endogenous Cdc42Palm at tip of axon ( Figure 6A ). 2-BP treatment disrupts this enrichment and diffusely disperses Cdc42Palm to entire cell ( Figure S6B ). These findings indicate that palmitoylation results in targeting and transporting Cdc42Palm to the tip of the axon, where it modulates axonal length and branching. Compared with WT neurons (n = 64), the normalized intensity of the endogenous Cdc42Palm at the tip of axons is decreased by 19% and 28% in the Zdhhc8 +/À (n = 64, p < 0.02) and Zdhhc8 À/À (n = 67, p < 0.001) neurons, respectively ( Figures   6A and 6B ), whereas the area of axon tip displayed no significant change among genotypes ( Figure S6C ). Reciprocally, Cdc42Palm abundance at axon shafts was increased by 2.1 and 2.9 times in the Zdhhc8 +/À (n = 64, p < 0.0001) and
Zdhhc8
À/À (n = 67, p < 0.0001) neurons, respectively, compared with WT littermates (n = 64) ( Figure 6C ). Thus, Zdhhc8 deficiency disrupts the subcellular localization of Cdc42Palm. To examine the role of endogenous Cdc42Palm in axonal development, an EGFP plasmid-based short hairpin RNA (shRNA) targeting Cdc42Palm was electroporated ex utero into E15.5 embryos. We immediately dissected cortices and established primary neuronal cultures to analyze neuronal polarity at DIV3 (Figures S6D and S6E ) and axon branching and length at DIV4 (Figures 6D-6G ). Whereas most cells (71%) have a single axon in control scrambled shRNA-transfected neurons, Cdc42Palm knockdown displayed a decrease in cells having a single axon (42%, p < 0.0001) ( Figures S6D and S6E ). The axons of Cdc42Palm knockdown neurons were significantly shorter than those of the control cells (60.3 ± 3.9 mm versus 112.1 ± 6.0 mm in WT, p < 0.0001; Figure S6F ). The length and number of dendrites were also significantly reduced in Cdc42Palm knockdown neurons ( Figures S6G and S6H ) at DIV3.
In addition, Cdc42Palm knockdown yielded significant reductions of primary axon length (225.3 ± 9.4 mm; n = 32, p < 0.001), axon branching (2.0 ± 0.3; n = 32, p < 0.01), and total axon length (354.8 ± 26.2 mm; n = 32, p < 0.01) compared to scrambled shRNA controls (primary axon length, 364.4 ± 26.2 mm; axon branching, 3.8 ± 0.5; total axon length, 545.3 ± 47.9 mm; n = 24) at DIV4 (Figures 6D-6G) .
To determine the role of Cdc42Palm on axon development in vivo, we used in utero electroporation of an shRNA targeting Cdc42Palm in newly divided neurons. Following electroporation at E14.5, axonal morphology of neurons was quantified at E17.5. Knockdown of Cdc42Palm resulted in a decrease in axon length (24%, n = 30, p < 0.0001) compared with scrambled control shRNA (n = 33) ( Figures S6I and S6J ). Axon branches in the ipsilateral cortical layers 2-4 in P8.5 brain sections were also quantified, following in utero electroporation of the shRNA at E15.5 ( Figures 6H and 6I ). Cdc42Palm knockdown resulted in a decrease in the number of axonal branches (30%, n = 18, p < 0.0001) compared with scrambled control shRNA (n = 18) ( Figures 6H and 6I ). These results suggest that Cdc42Palm modulates neuronal polarity, axonal elongation, and branching.
ZDHHC8 Regulates AKT/GSK3 Signaling
Three major classes of Cdc42 effectors include N-WASP (neural Wiskott-Aldrich syndrome protein); PAK (p21-activated kinases), which regulates actin polymerization and stabilization; and PAR (partitioning-defective) proteins, which modulate the PI3K/Akt/Gsk3 signaling pathway and regulate neuronal polarity, axon extension, and branching by transducing upstream signals to reorganization of axonal microtubules (Iden and Collard, 2008) . Data are shown as means ± SEM. *p < 0.05; **p < 0.001; ***p < 0.0001; Student's t test. See also Figure S4 .
The phosphatidylinositol 3-kinase (PI3K) signaling cascade is necessary for axonal growth during polarization (Shi et al., 2003) . PI3K activates Akt by phosphorylation at Thr-308 and Ser-473 via PIP3 phosphoinositide-dependent kinase (Yoshimura et al., 2006) . Activated Akt phosphorylates Gsk3b at Ser-9 and inactivates its kinase activity (Yoshimura et al., 2006) . Inactivation of Gsk3b is necessary for efficient axon elongation (Zhou et al., 2004) . During neuronal polarization, both PI3K and Akt are selectively transported to and enriched at the tip of individual neurites, signaling the progression from nonpolarized stage 2 to polarizing stage 3 (Shi et al., 2003) . Localized activation of Cdc42 at the leading edge recruits the Par3-Par6-PKCz polarity complex, leading to Rac/PI3K activation (Nishimura et al., 2005) , or directly binds to the p110b catalytic subunit isoform of PI3K, resulting in increased kinase activity and downstream Akt phosphorylation (Fritsch et al., 2013) .
We electroporated an shRNA targeting Cdc42Palm ex utero into E15.5 embryos and immediately dissected cortices and established primary neuronal cultures ( Figure 7A ). Quantification confirmed that Cdc42Palm knockdown significantly reduced See also Figure S5 .
axon-tip intensity of pAkt (33%, n = 24, p < 0.001), compared to control neurons (n = 24) ( Figure 7B ). As expected, axon-tip intensity of pGsk3b (36%, n = 30, p < 0.05) was also reduced by the Cdc42 Palm knockdown ( Figures 7C and 7D ). We then asked whether Zdhhc8 deficiency disrupts the subcellular localization of PI3K, pAkt, and pGsk3b. In stage 3 neurons, Zdhhc8 deficiency resulted in a slight decrease in pAkt staining within the soma (16%, n = 20, p < 0.05) (Figures 7E  and 7F ). pAkt staining intensity at tip of axon was also decreased by 13% and 24% in the Zdhhc8 +/À (n = 20, p < 0.05) and Zdhhc8 À/À (n = 20, p < 0.005) neurons, respectively, compared with WT neurons (n = 20) (Figures 7E and 7F) . Similarly, pGsk3b intensity at the tip of axons was also decreased by 14% and 25% in the Zdhhc8 +/À (n = 20, p < 0.05) and Zdhhc8 À/À (n = 20, p < 0.003) neurons, respectively, compared with WT neurons (n = 20) (Figures 7G and 7H ). Taken together, our results suggest that ZDHHC8 is required for optimal Akt/Gsk3b signaling at the tip of the growing axons and that this effect is mediated at least in part via palmitoylation and axonal tip enrichment of Cdc42. Notably, altered phosphorylation of Akt and Gsk3b is also evident in western blot assays of PFC lysates of 8-week-old Zdhhc8-deficient mice. pAkt (Ser473), a marker for Akt activation, was reduced 18% and 22% in the PFC of Zdhhc8 +/À (6 mice, n = 18, p < 0.05) and Zdhhc8 À/À (6 mice, n = 18, p < 0.005), respectively, as compared with WT littermates (six mice, n = 18) ( Figures 8A and 8B ). pGsk3b (Ser9) was reduced 19% and 29% in the Zdhhc8 +/À (six mice, n = 18, p < 0.005) and Zdhhc8 À/À (six mice, n = 18, p < 0.001) as compared with WT littermates (six mice, n = 18), respectively ( Figures 8A and 8B) . Importantly, Df(16)A +/À mice, with only one intact copy of Zdhhc8, show a significant reduction in the levels of pAkt (25%; 12 mice, n = 24, p < 0.05) and pGsk3b (19%; 12 mice, n = 24, p < 0.05), as compared with WT littermates (12 mice, n = 24) ( Figures 8C and 8D) .
If alterations of PI3K/Akt/Gsk3b signaling emerge during brain development, we might be able to reverse deficits in axonal branching by decreasing Gsk3b activity in developing Zdhhc8 À/À mice. To this end, following electroporation with EGFP plasmids at E15.5, pups were treated with DMSO or SB216763 (2 mg/kg i.p.), a Gsk3b inhibitor, every day from P2 to P7. Compared to DMSO-treated Zdhhc8 À/À mice (n = 15, four brains), Zdhhc8 À/À mice treated with SB216763 (n = 15, four brains), showed a 50% increase in the number of axon branches in the ipsilateral layers 2/4 ( Figures 8E-8G ) reaching the number of axon branches in WT mice treated with DMSO (n = 15, four brains). Moreover, we observed that contralateral primary axonal branches were increased by 72% in Zdhhc8
mice treated with SB216763 (n = 16, four brains), compared to Zdhhc8 À/À mice treated with DMSO (n = 12, four brains), and restored to the level observed in WT mice treated with DMSO (n = 12, four brains) ( Figures 8H-8J ). These findings establish a causal relationship between altered AKT/GSK3b signaling and Zdhhc8-dependent axonal branching in vivo.
DISCUSSION
The emerging picture from psychiatric genetics is one of substantial mutational heterogeneity. Modeling in animals a few selected mutations with robust and specific disease associations makes possible gaining insights into fundamental biological mechanisms that underlie disease pathogenesis and pathophysiology. In that context, our study provides a series of insights into the mechanisms governing axonal growth and their relation to the psychiatric and cognitive phenotypes associated with a well-established CNV predisposing to schizophrenia. Using a multipronged approach, we show that impaired palmitoylation affects axonal growth both in vitro and in vivo and provide evidence that altered palmitoylation of key axonal proteins emerging as a result of the 22q11.2 deletion results in deficits in axonal arborization and connectivity that affect the formation and function of neural circuits. Our analysis focuses on ZDHHC8 palmitoyltransferase, encoded by a gene located at the human 22q11.2 deletion locus. Our findings strongly suggests that Zdhhc8 deficiency accounts for many of the deficits in axonal morphology and synaptic contacts emerging as a result of a hemizygous deletion of the mouse syntenic 22q11.2 locus and reinforce the notion that reduction in the dosage of ZDHHC8 is crucial for establishing altered levels of short-and long-range connectivity in neurons carrying a deletion of the orthologous 22q11.2 locus.
Identification of bone fide substrates of ZDHHC8, which included a preponderance of proteins involved in axonal growth, facilitated elucidation of the mechanistic basis of the observed effects. Although it is very likely that the observed axonal phenotypes are caused by combined underpalmitoylation of more than one of the substrates, we identified a palmitoylated form of Cdc42 (cell division cycle 42), a RhoGTPase previously shown to modulate neuronal polarity and elongation as a key molecular mediator of the effect of altered palmitoylation on axonal growth. Moreover, our genetic and pharmacological rescue analysis provided evidence that the effect of ZDHHC8 on axon growth is mediated in part via Cdc42-dependent modulation of Akt/ Gsk3b signaling in the tip of the axon.
Although many psychiatric disorders, such as schizophrenia, emerge during adolescence and early adulthood, behavioral abnormalities including cognitive impairments are often apparent in a portion of patients before diagnostic criteria are met (Brewer et al., 2006) . Moreover, genes and cellular pathways implicated in disease risk play important roles both in the developing and the mature brain. Both the temporal expression and spatial expression of ZDHHC8 appear to coincide with peak periods of cortical synaptogenesis, where the enzyme may be critical during late embryogenesis and early postnatal life in establishing formation of short-and long-range connection of neurons that have migrated into their final destinations. In that respect, restoring axonal branching during early postnatal development (by treating mutant pups from P2 to P7 with SB216763) strongly suggests that early intervention that restores the function of this disease pathway may have beneficial effects. However, ZDHHC8 continues to be expressed at high levels in the cortex through adulthood, and it remains possible that in addition to its role in the initial formation of cortical circuits, ZDHHC8 function may continue to play an important role in the adult brain in regulating synaptic plasticity of these circuits.
Our results inform both the neural and genetic mechanisms of the disease. First, in schizophrenia and various developmental and psychiatric disorders, dysconnectivity between and within brain regions is thought to underlie emergence and severity of symptoms across many psychological domains and brain systems (cognitive, affective, social, motor, and perceptual). The exact mechanisms behind the spatiotemporal pattern of dysconnectivity are unknown and likely involve changes in local neural dynamics as well as alterations in anatomical scaffolding (e.g., axonal targeting and synaptogenesis in many brain areas) (Arguello and Gogos, 2012) . Our findings advance our understanding of how mutations predisposing to psychiatric and cognitive phenotypes impact circuits and offer one molecular and cellular basis for the structural dysconnectivity in psychiatric and neurodevelopmental disorders implicating the Zdhhc8 gene and neuronal protein palmitoylation in this process. In that respect, our observation that Zdhhc8 deficiency can lead to a specific disruption of vHPC synchrony with the mPFC and impair WM performance was particularly instructive in highlighting the necessity of intact terminal arborization of vHPC projections to mPFC in normal spatial WM. Although appropriately designed rescue studies are needed to establish an unequivocal link between Zdhhc8 and hippocampal-cortical synchrony, our findings suggest an important role for palmitoylation in shaping efficient long-range connectivity between brain structures.
Second, an emerging view of schizophrenia is that rare alleles contribute significantly to a large proportion of overall genetic risk, whereas secondary modifiers (other rare or common alleles) that regulate the function of key cellular signaling pathways determine the trajectory and severity of the clinical manifestations resulting from a primary disease-causing mutation. In that context, it is worth noting that an increasingly strong link between a dysregulation of Akt and Cdc42 signaling and schizophrenia is emerging in humans and an association between schizophrenia and common Akt1 and Cdc42 genetic variants has been reported in several patient cohorts (Arguello and Gogos, 2008; Gilks et al., 2012; Ide and Lewis, 2010) .
It is also important to consider the implications of our findings for the 22q11.2 locus-associated risk. Existing structural and functional neuroimaging work in 22q11.2 deletion carriers have detected structural abnormalities in white-matter volumetric and DTI measures as well as altered resting-state functional connectivity Baker et al., 2011; Ottet et al., 2013; Schreiner et al., 2014) . Together these studies found an overall global loss of connectivity as well as deficits in longrange connectivity in children with 22q11.2 deletions. Our findings of microscopic structural alterations in axonal branching in conjunction with current and previous finding of altered synaptic transmission and plasticity in cortical synapses of Df(16)A +/À mice (Fé nelon et al., 2011 (Fé nelon et al., , 2013 offer a plausible neural substrate that may underlie the mesoscopic scale neuroimaging findings. In addition, accumulating data link neuroimaging measures with the psychosis phenotype in 22q11.2 deletion carriers, providing support for the notion that structural and functional dysconnectivity is particularly relevant to the psychosis phenotype in 22q11DS (Kates et al., 2015; Perlstein et al., 2014; Jalbrzikowski et al., 2014; Ottet et al., 2013) . In that respect, our data suggest that the altered axonal connectivity that emerges as a result of deficits in neuronal palmitoylation contribute to the psychiatric deficits associated with the 22q11 deletion. Our findings should be interpreted in the context of decreases in the dosage of neighboring genes that would have a cumulative effect on the properties of neural networks, but the molecular substrates identified here may inform new treatments of the 22q11.2-associated psychiatric symptoms.
Overall, our results demonstrate how bona fide mutations interact with disease-associated signaling pathways that can mediate (and therefore also modify) the effects of a primary mutation on a cellular substrate (axonal connectivity). Translating interaction among primary mutations and signaling pathways at the levels of circuits and neural systems represents a decisive step toward valuable mechanistic insights into the pattern and severity of cognitive and psychiatric symptoms and thus can provide a key to understanding genetic and neural mechanisms underlying disease risk.
EXPERIMENTAL PROCEDURES
Zdhhc8 and Df(16)A +/-Transgenic Mice
Zdhhc8 knockout mice were generated and genotyped as previously described (Mukai et al., 2004) . The Df(16)A +/À mice were generated and genotyped as previously described . The expected reduction or elimination of Zdhhc8 transcript levels in the brain was confirmed by quantitative real-time PCR (Mukai et al., 2008) . All animal procedures were conducted according to protocols approved by the Institutional Animal Care and Use Committee established by Columbia University under federal and state regulations.
Electroporatlon In Utero
Pregnant mothers with E14.5-16.5 embryos were anaesthetized, and a 1 inch incision was made and one uterine horn removed. A total of 0.1-0.5 ml DNA (1-2 mg/ml) was injected into one ventricle. Four to five 40-48 V pulses were applied, each pulse lasting 50 ms, with a 1 s pause between each pulse using an ECM-830 square wave electroporatoror (BTX) as previously described (Saito, 2002) .
Drug Injection SB216763 was dissolved in DMSO (20 mg/ml) as the stock solution. Before each injection, the stock solution was freshly diluted to 2 mg/ml with PEG400. Final concentration for each pup is 2 mg/kg. Mice were treated with either control DMSO or SB216763 (2 mg/kg i.p.) every day from P2 to P7 at 9 a.m. Mice were perfused with PBS and 4% paraformaldehyde at 5 p.m. in P7. ABE assay, expression constructs, immunocytochemistry, immunohistochemistry, image acquisition and quantification, cell culture, transfection, western blot, behavior analysis, electrophysiology, and frontal cortex slice preparation are described in detail in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures and can be found with this article at http://dx.doi.org/10.1016/j. neuron.2015.04.003.
